Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Adjuvant Treatment in Extensive Unilateral Retinoblastoma Primary Enucleated

NCT02870907 is registered in ClinicalTrials.gov with Institut Curie as lead sponsor.

NCT NCT02870907
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02870907 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Adjuvant Treatment in Extensive Unilateral Retinoblastoma Primary Enucleated
Lead sponsor
Institut Curie
Phase
Phase 2
Overall status
Active, not recruiting
Start date
March 18, 2010
Completion date
March 1, 2031
Enrollment
195 (estimated)
Sites
27

Conditions

As the registry lists them; a condition with its own page is linked.

retinoblastoma